Healthcare Asia Magazine on MSN
Body fluid analysis market to hit $3.65b on neurological and cancer demand
Speciality diagnostics widen across multiple body fluid categories in hospital laboratories. The global body fluid analysis ...
According to MarketsandMarkets™, the Body Fluid Analysis Market is projected to grow from about USD 2.62 billion in 2026 to ...
Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global ...
IMU Biosciences partners with Waters to advance IMU’s AI-driven immunology platform to transform diagnosis and monitoring: London, UK Friday, June 26, 2026, 12:00 Hrs [IST] IMU ...
Quest Diagnostics’ DGX Haystack MRD test recently received approval from the New York State Department of Health's (“NYSDOH”) ...
Waters Corporation (NYSE: WAT) and IMU Biosciences have formed a strategic partnership to advance an AI-powered immune ...
IMU’s AI platform unlocks unprecedented immune insights for cancer and other diseases, measuring 100M+ data points from a ...
A large body of research publications covering hematological disorders, such as acute myeloid leukemia (AML) and multiple myeloma (MM), demonstrates that measurable minimal disease (MRD) neg ...
This guide examines the core principles that underpin robust flow cytometry workflows, connecting established best practices with modern spectral capabilities to help laboratories generate more ...
According to MarketsandMarkets, the Body Fluid Analysis Market is projected to grow from about USD 2.62 billion in 2026 to USD 3.65 billion ...
The following article is an opinion piece written by Rosa Sottile, PhD. The views and opinions expressed in this article are those of the author and do not necessarily reflect the official position of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results